GCM
LMAT icon

Graham Capital Management’s LeMaitre Vascular LMAT Stock Holding History

Graham Capital Management’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$278K Sell
2,548
-2,502
-50% -$238K 0.01% 843
2025
Q4 		$410K Sell
5,050
-2,089
-29% -$180K 0.01% 711
2025
Q3 		$625K Sell
7,139
-2,286
-24% -$204K 0.01% 536
2025
Q2 		$783K Buy
9,425
+2,178
+30% +$182K 0.01% 661
2025
Q1 		$608K Buy
7,247
+1,757
+32% +$163K 0.01% 729
2024
Q4 		$506K Buy
+5,490
New +$528K 0.01% 731

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Graham Capital Management's LMAT Position: Q1 2026 in Review

Graham Capital Management reduced its LeMaitre Vascular (LMAT) stake by 50% in Q1 2026, selling an estimated $238K and leaving 2,548 shares worth $278K. The position accounts for 0.01% of the portfolio, ranked #843.

Graham Capital Management first reported a position in LMAT in Q4 2024 and has held it in 6 quarters since. The position peaked at $783K in Q2 2025. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Graham Capital Management held 2,548 shares of LeMaitre Vascular worth $278K as of Q1 2026.
  • Graham Capital Management sold 2,502 LeMaitre Vascular shares in Q1 2026, an estimated $238K.
  • LeMaitre Vascular made up 0.01% of Graham Capital Management's portfolio in Q1 2026, its #843 holding.
  • Graham Capital Management first reported a position in LeMaitre Vascular in Q4 2024 and has held it in 6 quarters since.
  • Graham Capital Management's LeMaitre Vascular position peaked at $783K in Q2 2025.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.